Patents Assigned to Amersham
  • Patent number: 6906185
    Abstract: Derivatives of 7-deaza-2?-deoxyguanosine are described. Also described is the use of such compounds in synthesis of nucleic acid polymers and in methods for determining a nucleotide base sequence.
    Type: Grant
    Filed: March 20, 1998
    Date of Patent: June 14, 2005
    Assignee: Amersham Biosciences Corp.
    Inventors: Carl W. Fuller, Mark McDougall, Shiv Kumar
  • Patent number: 6906171
    Abstract: The synthesis of peptides comprising disulphide bridges is challenging since it is difficult to ensure that the correct cysteine residues combine to form the desired disulphide bridges. The present invention describes novel protection techniques useful in the preparation of peptides. Described is a process for the deprotection of an Acm-, MBzl- and/or tBu-protected thiol which comprises reacting said protected thiol with an acid in the presence of an oxidising agent at a temperature sufficient to effect deprotection and generation of disulphide bonds.
    Type: Grant
    Filed: January 18, 2002
    Date of Patent: June 14, 2005
    Assignee: Amersham Health AS
    Inventor: Alan Cuthbertson
  • Patent number: 6902657
    Abstract: A low molecular weight non-entangled polyvinylpyrrolidone for use as a separation media for microchannel electrophoretic separation. The separation media may be used in a system in which multiple samples of small compounds are injected into a single microchannel at time spaced intervals followed by a continuous detection interval.
    Type: Grant
    Filed: June 15, 2001
    Date of Patent: June 7, 2005
    Assignee: Amersham Biosciences Corp.
    Inventors: Marek Minarik, Melanie M. Mahtani
  • Patent number: 6901281
    Abstract: The invention provides a method of magnetic resonance imaging of regional blood oxygenation which comprises administering into the vasculature of a vascularized human or non-human animal subject a T2 blood pool contrast agent, detecting a magnetic resonance signal from at least part of the vasculature of said subject into which said contrast agent distributes, and manipulating said signal to generate an indication of the partial pressure of oxygen (pO2) in at least part of said vasculature.
    Type: Grant
    Filed: March 22, 2001
    Date of Patent: May 31, 2005
    Assignee: Amersham Health AS
    Inventors: Atle Bjørnerud, Kenneth Edmund Kellar, Karen Briley-Saebo, Lars Johansson
  • Patent number: 6900019
    Abstract: This invention provides a simple and convenient, single stage, single vessel cell extraction and assay method which is suitable for the extraction and measurement of a range of different types of analyte which occur as cellular components. The invention also provides kits of reagents suitable for performing cellular extraction and measurement as a single stage, single vessel process.
    Type: Grant
    Filed: February 23, 1998
    Date of Patent: May 31, 2005
    Assignee: Amersham Biosciences UK Limited
    Inventor: Jeffrey Kenneth Horton
  • Patent number: 6887990
    Abstract: A method for purifying an oligonucleotide that comprises providing an oligonucleotide attached to a substrate, wherein the oligonucleotide contains phosphate protecting groups; contacting the oligonucleotide with a reagent, e.g., an organic amine, that cleaves the phosphate protecting groups from the oligonucleotide without detaching the oligonucleotide from the substrate; isolating the oligonucleotide attached to the substrate from the cleaved phosphate protecting groups; and cleaving the oligonucleotide from the substrate. This method provides crude oligonucleotide mixtures that are easier to purify and from which the desired full-length oligonucleotide product can be isolated in higher yields.
    Type: Grant
    Filed: February 5, 2000
    Date of Patent: May 3, 2005
    Assignee: Amersham Biosciences Corp
    Inventors: Anila Bhan, Lars Holmberg
  • Publication number: 20050089918
    Abstract: This invention provides a simple and convenient, single stage, single vessel cell extraction and assay method which is suitable for the extraction and measurement of a range of different types of analyte which occur as cellular components. The invention also provides kits of reagents suitable for performing cellular extraction and measurement as a single stage, single vessel process.
    Type: Application
    Filed: November 17, 2004
    Publication date: April 28, 2005
    Applicant: AMERSHAM BIOSCIENCES UK LIMITED
    Inventor: Jeffrey Horton
  • Patent number: 6875420
    Abstract: Disclosed herein are agents for enhancing the contrast in an ultrasound image. These agents are extremely small bubbles, or “microbubbles,” comprised of specially selected gases. The microbubbles described herein exhibit long life spans in solution and may be produced at a size small enough to traverse the lungs, thus enabling improved ultrasound imaging of the cardiovascular system and other vital organs. Also disclosed herein is a method for selecting gases from which contrast agents may be produced. The method is based on calculations using inherent physical properties of gases and describes a means to associate the properties of a gas with the time for dissolution of microbubbles comprised of the gas.
    Type: Grant
    Filed: July 18, 1997
    Date of Patent: April 5, 2005
    Assignee: Amersham Health AS
    Inventor: Steven C. Quay
  • Patent number: 6875573
    Abstract: Thermostable DNA polymerases both in native form and having single amino acid substitutions and optionally N-terminal deletions are disclosed. These polymerases exhibit a substantial improvement of DNA sequencing performance compared to Taq DNA polymerase. The instant DNA polymerases also possess improved salt tolerance.
    Type: Grant
    Filed: July 8, 2002
    Date of Patent: April 5, 2005
    Assignee: Amersham Biosciences Corp
    Inventors: Carl Fuller, Joseph Szasz
  • Patent number: 6872380
    Abstract: The present invention provides a process for the preparation of an MR contrast agent, said process comprising: i) obtaining a solution in a solvent of a hydrogenatable, unsaturated substrate compound and a catalyst for the hydrogenation of said substrate compound; ii) introducing said solution in droplet form into a chamber containing hydrogen gas (H2) enriched in para-hydrogen (p-1H2) and/or ortho-deuterium (o-2H2) whereby to hydrogenate said substrate to form a hydrogenated imaging agent; iii) optionally subjecting said hydrogenated imaging agent to a magnetic field having a field strength below earth's ambient field strength; iv) optionally dissolving said imaging agent in an aqueous medium; v) optionally separating said catalyst from the solution of said imaging agent in said aqueous medium; vi) optionally separating said solvent from the solution of said imaging agent in said aqueous medium; and vii) optionally freezing the solution of said imaging agent in said aqueous medium.
    Type: Grant
    Filed: November 16, 2001
    Date of Patent: March 29, 2005
    Assignee: Amersham Health AS
    Inventors: Oskar Axelsson, Charlotte Olofsson, Axel Morgenstjerne, Georg Hansson, Haukur Johannesson, Jan-Henrik Ardenkjaer-Larsen
  • Patent number: 6870185
    Abstract: Structures and methods that facilitate integration and/or isolation of various functions in a microchip system are disclosed. In one embodiment, the integration of the functions is by a multi-chip, sliding linear valve approach. The chips are in continued physical contact. In a second embodiment, the chips are separated and rejoined when they are moved to the preferred position. Surface coating of the joining edges helps prevent leakage and keeps liquid in the capillary channels for both embodiments. Another embodiment relates to miniature valves. Several designs were disclosed, including the linear, edge-contact sliding valve approach. Method to fabricate very small, high aspect ratio holes in glass was also disclosed, which facilitates the above embodiments.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: March 22, 2005
    Assignee: Amersham Biosciences (SV) Corp
    Inventors: David John Roach, Jing Ni, Iuliu-Ioan Blaga, Owe Salvén, Stevan Bogdan Jovanovich
  • Patent number: 6855503
    Abstract: Exploitation of suitably functionalized heterocyclic molecules, in the design and synthesis of Fluorescence Resonance Energy Transfer (FRET) cassettes and their corresponding dideoxynucleotide terminators culminated into efficient reagents for DNA sequencing. Additionally, these FRET cassettes/terminators, of the present invention, derived from different classes of heterocyclic systems have high potential to be used for general labelling of biological molecules to generate highly sensitized signals. Their preparation, energy transfer efficiency, and use as labels, specifically, in DNA sequencing reactions is disclosed.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: February 15, 2005
    Assignee: Amersham Biosciences Corp
    Inventors: Satyam Nampalli, Weihong Zhang, Sudhakar Rao, Shiv Kumar
  • Patent number: 6852230
    Abstract: Method for desalting an aqueous liquid containing a charged substance comprising the steps of: (i) contacting liquid (I) with an ion-exchanger (1) under conditions permitting binding between ion-exchanger and substance, said ion-exchanger comprising a base matrix carrying an ion-exchange ligand (Ligand 1) with the opposite charge compared to the substance, (ii) desorbing said substance from said ion-exchanger by the use of a liquid (liquid (II)). Wherein: (A) ion-exchanger (1) is an ion-exchanger: (a) that can bind the substance in an aqueous reference liquid at ionic strength corresponding to 0.1 M NaCl, preferably 0.25 M NaCl; and (b) permits a breakthrough capacity at the pH provided by liquid (I) which is more than 2 mg/ml of gel, at a breakthrough of 10% and linear flow velocity of 300 cm/h; and (B) in step (ii) the pH of liquid (11) is adjusted to a pH value where the charge difference between the substance, the ligand and/or the ion-exchanger is lowered.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: February 8, 2005
    Assignee: Amersham Biosciences AB
    Inventors: Makonnen Belew, Bo-Lennart Johansson, Jean-Luc Maloisel
  • Patent number: 6847035
    Abstract: The present invention relates to devices and methods for determining the masses of particles by measuring the time between a first event such as a sample (5) being ionized, (or a beam of electromagnetic radiation being scattered by a particle (15) and electromagnetic radiation scattered by said particle being detected by a detection means,) and a second event in which a beam (21) of electromagnetic radiation is scattered by a particle (15) from said ionized sample and electromagnetic radiation (25) from said beam (21) scattered by said particle (15) is detected by a detection means (11).
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: January 25, 2005
    Assignee: Amersham Biosciences UK Limited
    Inventor: Shiv Sharma
  • Patent number: 6843427
    Abstract: Method and device for continuously producing a coherent layer of a liquid/melt of even thickness by means of centrifugal action along the entire periphery of a rotating disk (13, 113), liquid/melt being supplied to the disk around its entire axis of rotation from means (12, 112) and leaving the disk as individual droplets. The means (12, 112) distributing the liquid/melt onto the disk (13, 113) has according to the invention essentially the same speed and direction of rotation as the disk, and the liquid/melt undergoes under the influence of centrifugal action circumferentially a spreading and change in velocity across the disk (13, 113) in contact with the same.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: January 18, 2005
    Assignee: Amersham Biosciences AB
    Inventors: Ralf Goran Andersson, Ingemar Jonsson
  • Patent number: 6841097
    Abstract: The invention refers to a method of controlling the porosity of porous spherical particles produced from a polysaccharide dissolved in a solvent, in which it can be gelled. The polysaccharide solution is finely divided by mechanical means into spherical droplets which are allowed to pass through a humid atmosphere and transferred to a capturing medium while controlling the temperature and humidity of humid atmosphere.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: January 11, 2005
    Assignee: Amersham Biosciences AB
    Inventors: Ralf Goran Andersson, Ingemar Jonsson
  • Publication number: 20050002865
    Abstract: Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.
    Type: Application
    Filed: December 15, 2003
    Publication date: January 6, 2005
    Applicant: Amersham Health AS
    Inventors: Jo Klaveness, Pal Rongved, Anders Hogset, Helge Tolleshaug, Alan Cuthbertson, Aslak Godal, Lars Hoff, Geir Gogstad, Klaus Bryn, Anne Naevestad, Dagfinn Lovhaug, Halldis Hellebust, Magne Solbakken
  • Patent number: D500555
    Type: Grant
    Filed: May 9, 2003
    Date of Patent: January 4, 2005
    Assignee: Amersham Biosciences AB
    Inventor: Karl-Gunnar Hellström
  • Patent number: D500856
    Type: Grant
    Filed: May 9, 2003
    Date of Patent: January 11, 2005
    Assignee: Amersham Biosciences AB
    Inventor: Karl-Gunnar Hellström
  • Patent number: D506261
    Type: Grant
    Filed: May 9, 2003
    Date of Patent: June 14, 2005
    Assignee: Amersham Biosciences AB
    Inventor: Karl-Gunnar Hellström